ArticleClinical pharmacology and therapeutics2025

Exposure-Response Relationships in Patients with Non-Small-Cell Lung Cancer and Other Solid Tumors Treated with Patritumab Deruxtecan (HER3-DXd).

Li Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.